Cargando…
Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer
BACKGROUND: Venous thromboembolism (VTE) is a leading cause of death among patients with cancer. Outpatients with cancer should be periodically assessed for VTE risk, for which the Khorana score is commonly recommended. However, it has been questioned whether this tool is sufficiently accurate at id...
Autores principales: | Muñoz Martín, Andrés J., Ortega, Israel, Font, Carme, Pachón, Vanesa, Castellón, Victoria, Martínez-Marín, Virginia, Salgado, Mercedes, Martínez, Eva, Calzas, Julia, Rupérez, Ana, Souto, Juan C., Martín, Miguel, Salas, Eduardo, Soria, Jose M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931103/ https://www.ncbi.nlm.nih.gov/pubmed/29588512 http://dx.doi.org/10.1038/s41416-018-0027-8 |
Ejemplares similares
-
A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective Cohorts
por: Muñoz, Andrés, et al.
Publicado: (2023) -
Direct oral anticoagulants for the treatment and prevention of venous thromboembolism in patients with cancer: current evidence
por: García-Escobar, I., et al.
Publicado: (2020) -
Predictive Ability of a Clinical-Genetic Risk Score for Venous Thromboembolism in Northern and Southern European Populations
por: Salas, Eduardo, et al.
Publicado: (2021) -
Clinical guide SEOM on venous thromboembolism in cancer patients
por: Muñoz Martín, A. J., et al.
Publicado: (2014) -
Pharmacological cancer treatment and venous thromboembolism risk
por: Muñoz Martín, Andrés J, et al.
Publicado: (2020)